Healthcare provider profile · identity verified

Ronnie T. Beamon, MD

Family Practice · DAVIDSON, NC · NPI 1477584316

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	370	37
Sertraline Hcl	Sertraline Hcl	352	33
Pantoprazole Sodium	Pantoprazole Sodium	315	46
Furosemide	Furosemide	228	30
Memantine Hcl	Memantine Hcl	194	17
Donepezil Hcl	Donepezil Hcl	191	22
Lisinopril	Lisinopril	190	30
Amlodipine Besylate	Amlodipine Besylate	184	23
Ceftriaxone	Ceftriaxone Sodium	173	56
Atorvastatin Calcium	Atorvastatin Calcium	164	23
Losartan Potassium	Losartan Potassium	156	18
Famotidine	Famotidine	134	20
Trazodone Hcl	Trazodone Hcl	125	17
Gabapentin	Gabapentin	124	13
Mirtazapine	Mirtazapine	124	15
Eliquis	Apixaban	123	19
Prednisone	Prednisone	108	15
Carbidopa-Levodopa	Carbidopa/Levodopa	103	suppressed
Carvedilol	Carvedilol	97	13
Escitalopram Oxalate	Escitalopram Oxalate	96	14
Lorazepam	Lorazepam	96	19
Tramadol Hcl	Tramadol Hcl	95	19
Potassium Chloride	Potassium Chloride	93	13
Metoprolol Succinate	Metoprolol Succinate	91	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	89	33
Meloxicam	Meloxicam	77	20
Duloxetine Hcl	Duloxetine Hcl	75	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	74	11
Xarelto	Rivaroxaban	71	suppressed
Lidocaine Hcl	Lidocaine Hcl	59	33
Latanoprost	Latanoprost	57	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	57	12
Omeprazole	Omeprazole	57	suppressed
Cephalexin	Cephalexin	56	21
Alendronate Sodium	Alendronate Sodium	50	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	49	suppressed
Buspirone Hcl	Buspirone Hcl	46	suppressed
Finasteride	Finasteride	43	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	43	16
Metformin Hcl	Metformin Hcl	41	suppressed
Levofloxacin	Levofloxacin	40	18
Citalopram Hbr	Citalopram Hydrobromide	39	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	39	suppressed
Torsemide	Torsemide	37	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	suppressed
Clonazepam	Clonazepam	33	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	31	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Montelukast Sodium	Montelukast Sodium	31	suppressed
Pravastatin Sodium	Pravastatin Sodium	31	suppressed
Allopurinol	Allopurinol	30	suppressed
Cholestyramine	Cholestyramine (With Sugar)	30	suppressed
Fluconazole	Fluconazole	30	suppressed
Spironolactone	Spironolactone	30	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	suppressed
Alprazolam	Alprazolam	26	suppressed
Atenolol	Atenolol	26	suppressed
Bupropion Hcl Sr	Bupropion Hcl	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	13
Rivastigmine	Rivastigmine	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Simbrinza	Brinzolamide/Brimonidine Tart	24	suppressed
Bumetanide	Bumetanide	23	suppressed
Clotrimazole	Clotrimazole	22	suppressed
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Lorazepam Intensol	Lorazepam	21	suppressed
Divalproex Sodium	Divalproex Sodium	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Timolol Maleate	Timolol Maleate	19	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	17	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	17	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Primidone	Primidone	17	suppressed
Silodosin	Silodosin	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Azithromycin	Azithromycin	16	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	16	suppressed
Morphine Sulfate	Morphine Sulfate	16	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	suppressed
Nyamyc	Nystatin	15	suppressed
Rivastigmine	Rivastigmine Tartrate	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	suppressed
Flecainide Acetate	Flecainide Acetate	14	suppressed
Fluticasone Propionate	Fluticasone Propionate	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Ranolazine Er	Ranolazine	14	suppressed
Rocklatan	Netarsudil Mesylat/Latanoprost	14	suppressed
Albuterol Sulfate	Albuterol Sulfate	13	suppressed
Anastrozole	Anastrozole	13	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	13	suppressed
Temazepam	Temazepam	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Cyclosporine	Cyclosporine	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Fetzima	Levomilnacipran Hcl	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Ursodiol	Ursodiol	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Clindamycin Hcl	Clindamycin Hcl	11	suppressed
Entacapone	Entacapone	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Restasis	Cyclosporine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error